New Study Confirms Pot Smokers are Happy, Well Adjusted and Successful

Not to be that person who says “I told you so,” but a new study has concluded that pot smokers are not a bunch of lazy slackers but indeed well-adjusted human beings who cross a large swath of society’s diverse types of individuals.

The landmark new study conducted by BDS Analytics, entitled “Cannabis Consumers are Happy Campers,” surveyed 2,000 California and Colorado adults, with a quota of 1,200 people who have used marijuana within the past six months.

The logic was to gather info from a population sample that was representative of the general public.

Read more at High Times

Study: Low-Dose THC Can Relieve Stress, but Too Much May Do the Opposite

The popular claim that cannabis relieves stress and helps one relax has just been confirmed in a new study.

However, don’t bogart that joint, my friend.

Researchers found that weed’s stress-relieving properties are most effective when micro-dosed. But too much can have the opposite effect.

Read more at High Times

Positive Effects of Medical Marijuana on Alzheimer’s Prevention

A preclinical study published in the Journal of Alzheimer’s Disease found that very small doses of tetrahydrocannabinol (THC), can slow the production of toxic clumps of beta-amyloid proteins in the brain, which are thought to kick start the progression of Alzheimer’s disease.

In a healthy brain, these protein fragments are broken down and eliminated. For those with Alzheimer’s disease, the fragments accumulate to form hard, insoluble plaques.

The study supports the results of previous research that found evidence of the protective effects of cannabinoids, including THC, on patients with neurodegenerative diseases.

Read more at High Times

GW Pharmaceuticals Files for FDA Approval After Report Confirms Success in Treating Epilepsy

GW Pharmaceuticals has chosen the perfect moment to file its cannabis-derived therapy, Epidiolex, with U.S. regulators.

The New England Journal of Medicine just published results from a Phase III study showing that GW’s Epidiolex (derived from cannabidiol) significantly reduced monthly convulsive seizures, especially in children with Dravet syndrome, one of the most difficult types of epilepsy to treat. Children can have dozens, even hundreds, of seizures per month.

GW Pharmaceuticals first reported in March 2016 that CBD-derived Epidiolex cut monthly convulsive seizures by 39 percent in children with Dravet syndrome, but full results of the 120-patient study were only published last week.

Read more at High Times

Foundation to Help Fund PTSD Research and Get Veterans Jobs in the Pot Industry

Dr. Sue Sisley, a psychiatrist and former clinical assistant professor at Arizona University (AU), is one of the nation’s foremost scientific experts on medical marijuana.

Although she’s never served in the military Sisley, wears or carries a dog tag stamped with the number “22,” as a constant reminder of how many American vets commit suicide each day—most suffering from post-traumatic stress disorder, according to data from the Department of Veterans Affairs.

“Even though we all realize that is a falsely low number… it is a horrific number,” Sisley told NewsMax Health, noting that veteran suicides far outnumber the national civilian average.

Read more at High Times

Pot vs. Pills: Will Cannabis Help End the Opioid-Abuse Epidemic?

With the election of Donald Trump and Republican majorities in Congress, the GOP has vowed to move forward with its longtime pledge to undo the Affordable Care Act. While it remains to be seen what approach the Republicans will take to replace the ACA, overhauling the country’s health-care system presents a timely opportunity to address an epidemic gripping the nation: the explosive growth in opioid addiction and abuse.

The numbers are staggering. The total number of opioid pain relievers prescribed in the United States jumped from 76 million in 1991 to 207 million in 2013. In that time, Americans accounted for nearly 100 percent of the hydrocodone sales in the world and 81 percent of oxycodone sales. This explosive growth in opioid use has resulted in a surge of opioid-related deaths. In 2015, opioids were involved in 33,091 deaths, a fourfold increase since 1999 that accounted for 63 percent of all drug-related deaths. As a result of this increase, drug-related deaths for the first time exceeded the number of deaths from car crashes in the United States.

With over two million Americans addicted to prescription painkillers and an additional 600,000 addicted to heroin, there’s a growing urgency to find alternative therapies that can slow or reverse this epidemic.

Read more at High Times

Study: Cannabis Reverses Aging Processes in Brain

Here’s some counterintuitive news for those who have been hammered all their lives with claims that cannabis causes memory loss.

A new study by scientists at the University of Bonn, written up in the journal Nature Medicine, found that aging mice treated with daily small doses of THC actually experienced a reversal of cognitive decline. That is, they started doing better on cognitive tasks, such as going though a maze.

The researchers foresee potential cannabis-based treatment to fend off dementia.

Read more at High Times

Yet Another Study: Sick People Dump Opiates for Marijuana

The anti-marijuana legalization cabal of law enforcement, pharmaceutical companies and the politicians they support have something right: In the states where marijuana is available, marijuana use increases. That is exactly the point, after all—and it’s a good thing!

As a new study published this week found, where marijuana use increases, there’s a significant decrease in the use of prescription opiates and other habit-forming drugs.

Researchers from Bastyr University, an “alternative medicine” university with campuses in Washington State and California, surveyed 2,774 adults who reported using cannabis at least once in the previous 90 days. Respondents came from all 50 states and 42 countries—and only 59 percent of respondents identified themselves as medical marijuana users.

Read more at High Times

Researchers Look at Cannabis to Help Treat Children’s Brain Tumors

Urged on by intelligent, proactive parents who were buying cannabidiol (CBD) online to give to their children with brain tumors, British scientists are now investigating whether, or how, CBD can be used to shrink brain tumors in children—a fact the parents have already confirmed.

“Increasingly families are using CBD, often at great expense,” said the project’s lead researcher, Professor Richard Grundy. “Presently, there is no evidence that it might be of benefit or even what dose to use or how often.”

The study will be carried out at the University of Nottingham’s Children’s Brain Tumor Research Center.

Read more at High Times

Study Shows MMJ Drastically Cuts Patients’ Use of Benzos

A Canadian company has announced that 40 percent of patients in a study of the effects of medical marijuana were able to quit their use of benzodiazepines within 90 days. After one year, 45 percent had discontinued their use of the powerful drugs.

Canabo Medical, Inc. operates 15 facilities, known as CMClinics, that offer cannabinoid therapies to patients referred by their treating physician.

The announcement was made earlier this month in Toronto by the executive chairman of Canabo, Dr. Neil Smith, at an event sponsored by the Canadian Consortium for the Investigation of Cannabinoids (CCIC). The CCIC is a federally registered, non-profit organization led by university professors and doctors from throughout Canada. The purpose of the CCIC is to advance the understanding of the role of cannabinoids in health and disease through research and education.

Read more at High Times